AU2020395111A1 - Engineering circular guide RNAs - Google Patents
Engineering circular guide RNAs Download PDFInfo
- Publication number
- AU2020395111A1 AU2020395111A1 AU2020395111A AU2020395111A AU2020395111A1 AU 2020395111 A1 AU2020395111 A1 AU 2020395111A1 AU 2020395111 A AU2020395111 A AU 2020395111A AU 2020395111 A AU2020395111 A AU 2020395111A AU 2020395111 A1 AU2020395111 A1 AU 2020395111A1
- Authority
- AU
- Australia
- Prior art keywords
- rna
- engineered
- sequence
- guide rna
- engineered guide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3519—Fusion with another nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/531—Stem-loop; Hairpin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/532—Closed or circular
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/34—Allele or polymorphism specific uses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/50—Methods for regulating/modulating their activity
- C12N2320/51—Methods for regulating/modulating their activity modulating the chemical stability, e.g. nuclease-resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962942725P | 2019-12-02 | 2019-12-02 | |
| US62/942,725 | 2019-12-02 | ||
| US202063112492P | 2020-11-11 | 2020-11-11 | |
| US63/112,492 | 2020-11-11 | ||
| PCT/US2020/062748 WO2021113264A1 (en) | 2019-12-02 | 2020-12-01 | Engineering circular guide rnas |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2020395111A1 true AU2020395111A1 (en) | 2022-06-02 |
Family
ID=76221931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2020395111A Pending AU2020395111A1 (en) | 2019-12-02 | 2020-12-01 | Engineering circular guide RNAs |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230036370A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4069830A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023504048A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115210366A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020395111A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3159799A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021113264A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3162908A1 (en) * | 2019-12-03 | 2021-06-10 | Beam Therapeutics Inc. | Synthetic guide rna, compositions, methods, and uses thereof |
| IL293671A (en) * | 2019-12-09 | 2022-08-01 | Astellas Pharma Inc | Antisense guide RNA with an additional functional region for target RNA editing |
| EP4158017A1 (en) * | 2020-05-26 | 2023-04-05 | Shape Therapeutics Inc. | Engineered circular polynucleotides |
| EP4240338A4 (en) * | 2021-01-04 | 2025-08-06 | Univ California | IN VIVO PROGRAMMABLE RNA EDITING BY RECRUITMENT OF ENDOGENOUS ADARS |
| JP2024504608A (ja) * | 2021-01-12 | 2024-02-01 | 北京大学 | 遺伝子操作rnaを使用した内因性adarの活用による標的化rnaの編集 |
| JP2024542983A (ja) * | 2021-10-26 | 2024-11-19 | シェイプ セラピューティクス インコーポレイテッド | Rna編集組成物及び使用方法 |
| EP4667570A1 (en) * | 2024-06-20 | 2025-12-24 | Johannes Gutenberg-Universität Mainz | Nucleic acid molecule complex for target pseudouridylation in mammalian cells |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150299702A1 (en) * | 2012-11-30 | 2015-10-22 | Aarhus Universitet | Circular rna for inhibition of microrna |
| CN106133138A (zh) * | 2013-08-22 | 2016-11-16 | 先锋国际良种公司 | 使用引导多核苷酸/cas内切核酸酶系统的基因组修饰及其使用方法 |
| AU2017283713B2 (en) * | 2016-06-17 | 2021-04-08 | Massachusetts Institute Of Technology | Type VI CRISPR orthologs and systems |
| WO2018237372A1 (en) * | 2017-06-23 | 2018-12-27 | Cornell University | RNA MOLECULES, METHODS FOR PRODUCING CIRCULAR RNA, AND METHODS OF TREATMENT |
| CN111328290A (zh) * | 2017-06-26 | 2020-06-23 | 博德研究所 | 用于靶向核酸编辑的基于crispr/cas-腺嘌呤脱氨酶的组合物、系统和方法 |
| US20200362334A1 (en) * | 2017-12-07 | 2020-11-19 | The Broad Institute, Inc. | High-throughput methods for identifying gene interactions and networks |
| MX2020006150A (es) * | 2017-12-15 | 2020-11-11 | Flagship Pioneering Innovations Vi Llc | Composiciones que comprenden polirribonucleotidos circulares y usos de las mismas. |
| CN119193702A (zh) * | 2018-09-06 | 2024-12-27 | 加利福尼亚大学董事会 | 经由改造的adar募集的rna和dna碱基编辑 |
| AU2020313143B2 (en) * | 2019-07-12 | 2024-04-04 | Peking University | Targeted RNA editing by leveraging endogenous adar using engineered RNAs |
| EP4158017A1 (en) * | 2020-05-26 | 2023-04-05 | Shape Therapeutics Inc. | Engineered circular polynucleotides |
-
2020
- 2020-12-01 CA CA3159799A patent/CA3159799A1/en active Pending
- 2020-12-01 EP EP20895262.2A patent/EP4069830A4/en active Pending
- 2020-12-01 WO PCT/US2020/062748 patent/WO2021113264A1/en not_active Ceased
- 2020-12-01 US US17/781,686 patent/US20230036370A1/en active Pending
- 2020-12-01 CN CN202080094276.4A patent/CN115210366A/zh active Pending
- 2020-12-01 JP JP2022530897A patent/JP2023504048A/ja active Pending
- 2020-12-01 AU AU2020395111A patent/AU2020395111A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3159799A1 (en) | 2021-06-10 |
| JP2023504048A (ja) | 2023-02-01 |
| CN115210366A (zh) | 2022-10-18 |
| WO2021113264A1 (en) | 2021-06-10 |
| US20230036370A1 (en) | 2023-02-02 |
| EP4069830A4 (en) | 2024-10-02 |
| EP4069830A1 (en) | 2022-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250270543A1 (en) | Programmable rna editing in vivo via recruitment of endogenous adars | |
| US20230036370A1 (en) | Engineering circular guide rnas | |
| US11963982B2 (en) | CRISPR/RNA-guided nuclease systems and methods | |
| US20240417706A1 (en) | Systems and methods for the treatment of hemoglobinopathies | |
| JP7720623B2 (ja) | 遺伝子操作されたadarのリクルートを介したrna及びdna塩基の編集 | |
| US8309356B2 (en) | Pseudocomplementary oligonucleotides for targeted gene therapy | |
| EP3010514B1 (en) | Double-stranded antisense nucleic acid with exon-skipping effect | |
| AU2024205204A1 (en) | Synthetic guide molecules, compositions and methods relating thereto | |
| AU2014306416B2 (en) | Compositions and methods for modulating RNA | |
| TW202024324A (zh) | 用於抑制17β-HSD第13型(HSD17B13)表現之RNAi藥劑、其組合物及使用方法 | |
| US20120149757A1 (en) | Compositions and methods for modulation of smn2 splicing | |
| TW202221120A (zh) | 用於治療代謝症候群之組成物及方法 | |
| AU2022203361A1 (en) | Compositions and methods for modulating RNA | |
| TW202444910A (zh) | 編碼casx之信使rna | |
| US20200263206A1 (en) | Targeted integration systems and methods for the treatment of hemoglobinopathies | |
| WO2022248879A1 (en) | Composition and method for adar-mediated rna editing | |
| CN114901823A (zh) | 诱导外显子50的跳读的反义核酸 | |
| CN115210376A (zh) | 诱导外显子51的跳读的反义核酸 | |
| TW202444904A (zh) | 用於抑制粒線體醯胺肟還原組分1(MARC1)之表現之RNAi藥劑、其醫藥組合物及使用方法 | |
| WO2026022136A1 (en) | Antisense oligonucleotides for the treatment of metabolic disorders | |
| WO2025128134A1 (en) | Crispri targeting alpha-synuclein | |
| WO2025061842A1 (en) | Gene editing tgm1 mutations for treating autosomal recessive congenital ichthyosis (arci) | |
| HK40078573A (en) | Antisense nucleic acid that induces skipping of exon 50 | |
| HK40082220A (en) | Antisense nucleic acid inducing skipping of exon 51 |